Department Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, California.
Stanford University Graduate School of Education, Palo Alto, California.
Pain Med. 2019 Oct 1;20(10):1925-1933. doi: 10.1093/pm/pnz001.
The National Institutes of Health's Patient-Reported Outcomes Measurement Information System (PROMIS)® includes an item bank for measuring misuse of prescription pain medication (PROMIS-Rx Misuse). The bank was developed and its validity evaluated in samples of community-dwelling adults and patients in addiction treatment programs. The goal of the current study was to investigate the validity of the item bank among patients with mixed-etiology chronic pain conditions.
A consecutive sample of 288 patients who presented for initial medical evaluations at a tertiary pain clinic completed questionnaires using the open-source Collaborative Health Outcomes Information Registry. Participants were predominantly middle-aged (M [SD] = 51.6 [15.5] years), female (62.2%), and white/non-Hispanic (51.7%). Validity was evaluated by estimating the association between PROMIS-Rx Misuse scores and scores on other measures and testing the ability of scores to distinguish among risk factor subgroups expected to have different levels of prescription pain medicine misuse (known groups analyses).
Overall, score associations with other measures were as expected and scores effectively distinguished among patients with and without relevant risk factors.
The study results supported the preliminary validity of PROMIS-Rx Misuse item bank scores for the assessment of prescription opioid misuse in patients visiting an outpatient pain clinic.
美国国立卫生研究院患者报告结局测量信息系统(PROMIS)® 包括一个用于测量处方止痛药滥用的项目库(PROMIS-Rx 滥用)。该库是在社区居住的成年人和成瘾治疗计划中的患者样本中开发并评估其有效性的。本研究的目的是调查该项目库在混合病因慢性疼痛患者中的有效性。
在一家三级疼痛诊所接受初始医疗评估的 288 名连续患者使用开源协作健康结果信息登记处完成了问卷调查。参与者主要为中年(M [SD] = 51.6 [15.5] 岁),女性(62.2%),白种人/非西班牙裔(51.7%)。通过估计 PROMIS-Rx 滥用评分与其他测量指标之间的关联以及测试评分区分预期具有不同水平处方止痛药滥用的风险因素亚组的能力(已知组分析)来评估有效性。
总体而言,与其他指标的评分相关性符合预期,评分能够有效区分有和无相关风险因素的患者。
研究结果支持 PROMIS-Rx 滥用项目库评分用于评估门诊疼痛诊所就诊患者阿片类药物处方滥用的初步有效性。